Your browser is no longer supported. Please, upgrade your browser.
Settings
IMMU Immunomedics, Inc. daily Stock Chart
IMMU [NASD]
Immunomedics, Inc.
Index- P/E- EPS (ttm)-1.62 Insider Own7.19% Shs Outstand194.02M Perf Week-1.81%
Market Cap2.52B Forward P/E- EPS next Y-1.50 Insider Trans19.65% Shs Float173.65M Perf Month-12.16%
Income-362.00M PEG- EPS next Q-0.34 Inst Own93.30% Short Float19.01% Perf Quarter-28.18%
Sales0.40M P/S6305.65 EPS this Y53.10% Inst Trans7.65% Short Ratio11.83 Perf Half Y-13.56%
Book/sh0.96 P/B13.54 EPS next Y10.20% ROA-63.30% Target Price25.30 Perf Year-46.68%
Cash/sh2.28 P/C5.70 EPS next 5Y- ROE-121.30% 52W Range11.55 - 27.33 Perf YTD-8.90%
Dividend- P/FCF- EPS past 5Y-14.80% ROI- 52W High-52.43% Beta1.95
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low12.55% ATR0.62
Employees346 Current Ratio7.90 Sales Q/Q- Oper. Margin- RSI (14)43.22 Volatility3.57% 5.06%
OptionableYes Debt/Eq0.04 EPS Q/Q-113.60% Profit Margin- Rel Volume0.98 Prev Close12.80
ShortableYes LT Debt/Eq0.04 EarningsMay 09 BMO Payout- Avg Volume2.79M Price13.00
Recom2.00 SMA200.55% SMA50-11.05% SMA200-25.99% Volume2,734,589 Change1.56%
Mar-27-19Initiated Berenberg Buy $40
Mar-04-19Initiated H.C. Wainwright Buy $28
Jan-18-19Downgrade Wells Fargo Outperform → Market Perform
Nov-08-18Resumed Jefferies Buy
Nov-05-18Initiated Morgan Stanley Overweight
Oct-19-18Initiated Piper Jaffray Overweight
Sep-17-18Initiated Goldman Buy $36
Jun-07-18Initiated B. Riley FBR, Inc. Buy $53
May-05-17Upgrade Wells Fargo Market Perform → Outperform
Oct-06-16Resumed Jefferies Buy
Jun-21-16Downgrade Wells Fargo Outperform → Market Perform
May-06-16Upgrade Jefferies Hold → Buy
Dec-04-15Downgrade Wells Fargo Outperform → Market Perform
Jul-29-15Downgrade Jefferies Buy → Hold
Aug-27-14Downgrade R. F. Lafferty Buy → Neutral $4
Jan-08-14Initiated Chardan Capital Markets Buy $9
Oct-02-13Reiterated Oppenheimer Outperform $6 → $8
Sep-10-13Initiated R. F. Lafferty Buy $8
Jun-03-13Initiated WallachBeth Buy $6
Aug-31-11Initiated Summer Street Research Buy $8
Jun-09-19 04:28PM  Notable Insider Buys This Past Week: American Airlines, MGM and More Benzinga
May-29-19 08:00AM  Immunomedics to Participate in Upcoming Healthcare Conferences GlobeNewswire
May-20-19 08:41AM  2 Biotech Names See Directors Direct Cash to Their Shares TheStreet.com
May-14-19 09:07PM  Edited Transcript of IMMU earnings conference call or presentation 9-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-09-19 07:40AM  Immunomedics: 1Q Earnings Snapshot Associated Press
07:00AM  Immunomedics Reports First Quarter 2019 Results and Provides Corporate Update GlobeNewswire
May-07-19 08:00AM  Immunomedics To Participate In Upcoming Healthcare Conferences GlobeNewswire
May-02-19 08:00AM  Immunomedics to Report First Quarter 2019 Results and Host Conference Call and Webcast on May 9, 2019 GlobeNewswire
Apr-29-19 12:46PM  Stocks making the biggest moves midday: Disney, Restaurant Brands, Gardner Denver, Target & more CNBC -5.39%
07:40AM  Immunomedics and Everest Medicines Announce Exclusive License Agreement for Sacituzumab Govitecan in East and Southeast Asia Excluding Japan GlobeNewswire
07:35AM  Immunomedics Announces Departure of Chief Medical Officer GlobeNewswire
Apr-26-19 01:11PM  Seattle Genetics (SGEN) Q1 Loss Narrows, Revenues Top Mark Zacks
12:07PM  Is Immunomedics, Inc. (IMMU) A Good Stock To Buy? Insider Monkey
07:17AM  Is Immunomedics, Inc. (NASDAQ:IMMU) Trading At A 34% Discount? Simply Wall St.
Apr-08-19 09:00AM  Immunomedics Announces Promotion Agreement With Janssen for Erdafitinib in the U.S. GlobeNewswire
Mar-07-19 04:01PM  Immunomedics Appoints Barbara G. Duncan to Board of Directors GlobeNewswire
Mar-04-19 08:00AM  Immunomedics to Participate in Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Mar-01-19 08:35AM  Research Report Identifies Axalta Coating, The Home Depot, Immunomedics, Kosmos Energy, Casa, and Ormat Technologies with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire +5.01%
07:51AM  Edited Transcript of IMMU earnings conference call or presentation 25-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
Feb-26-19 08:30AM  Lawsuit for Investors in NASDAQ: IMMU shares against Immunomedics, Inc. announced by Shareholders Foundation GlobeNewswire +6.98%
07:56AM  The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote Benzinga
07:05AM  Immunomedics Inc (IMMU) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-25-19 05:54PM  CLASS ACTION UPDATE for IMMU, ALKS and SVXY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:01PM  Immunomedics Reports Results For Period Ended December 31, 2018, Strengthens Board And Announces Senior Leadership Changes GlobeNewswire
03:45PM  DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Stockholders of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline- February 25, 2019 ACCESSWIRE
03:16PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DNKEY, IMMU, PRGO and DXC GlobeNewswire
02:19PM  CLASS ACTION UPDATE for IMMU, DXC and W: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:44PM  DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline- February 25, 2019 ACCESSWIRE
12:30PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of IMMU, YRIV, MAXR and SVXY GlobeNewswire
10:43AM  DEADLINE ALERT - IMMU, ALKS & DXC - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Feb-24-19 10:50PM  IMMUNOMEDICS 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU Business Wire
06:06PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DXC Technology, Immunomedics, Natural Health, and Maiden Holdings and Encourages Investors to Contact the Firm GlobeNewswire
02:24PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline IMMU ACCESSWIRE
01:57PM  CLASS ACTION UPDATE for SOGO, IMMU, W and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:42PM  DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline- February 25, 2019 ACCESSWIRE
11:40AM  IMMU, ALKS & DXC - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
10:55AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARLO, IMMU, MKL and SVXY GlobeNewswire
Feb-22-19 10:50PM  Immunomedics 72 Hour Deadline Alert: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU Business Wire
05:27PM  CLASS ACTION UPDATE for IMMU, GSM, TYME and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
03:52PM  DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
01:54PM  CLASS ACTION UPDATE for YRCW, IMMU, MKL and MAXR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:07PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Immunomedics, Inc. GlobeNewswire
12:51PM  DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
12:35PM  DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
11:13AM  CLASS ACTION UPDATE for IMMU, ALKS, UXIN and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:00AM  Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) & DXC Technology Company (DXC) - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Feb-21-19 07:00PM  CLASS ACTION UPDATE for YRCW, IMMU, W and TAP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:57PM  Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Immunomedics, Inc. (IMMU) GlobeNewswire
03:49PM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
02:13PM  CLASS ACTION UPDATE for IMMU, MKL, ATVI and BRS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:48PM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
11:53AM  CLASS ACTION UPDATE for IMMU, DBVT, DXC and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:47AM  Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) & DXC Technology Company (DXC) Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Feb-20-19 07:50PM  CLASS ACTION UPDATE for ARLO, SOGO, IMMU and DXC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
05:25PM  KESSLER TOPAZ MELTZER & CHECK, LLP: Final Deadline Reminder for IMMUNOMEDICS, INC. Investors IMMU GlobeNewswire
05:05PM  Immunomedics Announces Publication of Triple-Negative Breast Cancer Data With Sacituzumab Govitecan in the New England Journal of Medicine GlobeNewswire
05:00PM  IMMU UPCOMING FEBRUARY 25th DEADLINE: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Securities Class Action Lawsuit; Expanded Class Period IMMU GlobeNewswire
04:22PM  Block & Leviton LLP Reminds Shareholders of Important Deadlines; IMMU, PRGO, YRC, W GlobeNewswire
04:20PM  6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline IMMU ACCESSWIRE
03:46PM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
02:21PM  CLASS ACTION UPDATE for IMMU, DBVT, YRIV and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:45PM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
11:54AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of YRCW, IMMU, W and AVP GlobeNewswire
10:44AM  Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) and DXC Technology Company (DXC) Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
09:52AM  CLASS ACTION UPDATE for IMMU, AXGN, ATVI and TYME: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-19-19 04:10PM  IMMU: Pawar Law Group Announces a Securities Class Action Lawsuit Against Immunomedics, Inc. IMMU ACCESSWIRE
03:42PM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
02:17PM  Block & Leviton LLP Reminds Shareholders of Important Deadlines; IMMU, PRGO, YRC, NHTC GlobeNewswire
01:36PM  CLASS ACTION UPDATE for SOGO, IMMU, GSM and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:41PM  Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) and DXC Technology Company (DXC) Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
12:27PM  February 25th Immunomedics (NASDAQ: IMMU) Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against Immunomedics, Inc.  IMMU GlobeNewswire
11:33AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DNKEY, GS, IMMU and MAXR GlobeNewswire
10:33AM  CLASS ACTION UPDATE for IMMU, PRGO, ALKS and VALE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:00AM  Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) and DXC Technology Company (DXC) and YRC Worldwide Inc. (YRCW): Bronstein, Gewirtz & Grossman, LLC Class Action Update GlobeNewswire
08:00AM  Immunomedics to Report Results for the Quarter and Six Months Ended December 31, 2018 and Host Conference Call and Webcast on February 25, 2019 GlobeNewswire
Feb-18-19 02:00PM  CLASS ACTION UPDATE for IMMU, DBVT, ATVI and TAP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:03AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DNKEY, GS, IMMU and MAXR GlobeNewswire
07:18AM  CLASS ACTION UPDATE for YRCW, IMMU, MKL and MHLD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-17-19 02:05PM  CLASS ACTION UPDATE for IMMU, DBVT, MU and TYME: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
02:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NVIDIA, DXC Technology, Immunomedics, and Natural Health and Encourages Investors to Contact the Firm GlobeNewswire
08:14AM  FOMC minutes, Walmart earnings What to know in the week ahead Yahoo Finance
07:17AM  CLASS ACTION UPDATE for YOGA, IMMU, ALKS and ASTE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-15-19 10:50PM  IMMUNOMEDICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU GlobeNewswire
07:07PM  INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc. Business Wire
03:42PM  IMMU UPCOMING DEADLINE: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important February 25th Deadline in Securities Class Action Lawsuit; Expanded Class Period IMMU GlobeNewswire
02:00PM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
11:43AM  CLASS ACTION UPDATE for IMMU, ASTE, SVXY and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:13AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of IMMU, YRIV, SVXY and UXIN GlobeNewswire
10:37AM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
09:58AM  JA Solar Holdings Co. Ltd. (JASO), Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
09:54AM  CLASS ACTION UPDATE for IMMU, DBVT, AXGN and MKL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-14-19 06:56PM  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Immunomedics, Inc. Investors GlobeNewswire
06:11PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
04:41PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline IMMU GlobeNewswire
04:16PM  CLASS ACTION UPDATE for XRAY, IMMU, ALKS and MAXR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:00PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Immunomedics, Inc. IMMU ACCESSWIRE
03:35PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Immunomedics, Inc. To Contact The Firm ACCESSWIRE
03:11PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline - February 25, 2019 ACCESSWIRE
12:35PM  Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) and DXC Technology Company (DXC) - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Immunomedics, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibody-based products for the targeted treatment of cancer. Its advanced antibody-drug conjugates are sacituzumab govitecan and labetuzumab govitecan, which are in advanced trials for various solid tumors and metastatic colorectal cancer, respectively. The company focuses on commercializing sacituzumab govitecan as a third-line therapy for patients with metastatic triple-negative breast cancer in the United States. The company also develops IMMU-140, a humanized antibody directed against an immune response target. Its other product candidates include products for the treatment of cancer and autoimmune diseases, including epratuzumab, an anti-CD22 antibody; veltuzumab, an anti-CD20 antibody; milatuzumab, an anti-CD74 antibody; and IMMU-114, a humanized anti-HLA-DR antibody. Immunomedics, Inc. has clinical collaboration with AstraZeneca and MedImmune, to evaluate Imfinzi, a human monoclonal antibody against PD-L1, with sacituzumab govitecan as a frontline treatment of patients with TNBC and urothelial cancer; collaboration agreement with The Bayer Group for the development of epratuzumab; clinical and preclinical collaborations with academic cancer institutions, identifying new cancer indications for sacituzumab govitecan and the biology of the Trop-2 antigen; and research collaboration with the Memorial Sloan Kettering Cancer Center to investigate Sacituzumab Govitecan and Labetuzumab Govitecan in preclinical cancer models. Immunomedics, Inc. has a partnership agreement with the Samsung BioLogics Co., Ltd. to manufacture hRS7, an Immunomedics proprietary humanized antibody. The company was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BALL BRYANChief Quality OfficerJun 20Buy13.355,00066,7505,000Jun 21 08:47 AM
Avoro Capital Advisors LLCDirectorJun 05Buy12.47250,0003,117,50020,000,000Jun 05 11:42 AM
Avoro Capital Advisors LLCDirectorJun 04Buy12.10500,0006,050,00019,750,000Jun 05 11:42 AM
Avoro Capital Advisors LLCDirectorJun 03Buy12.19785,5399,575,72019,250,000Jun 05 11:42 AM
Avoro Capital Advisors LLCDirectorMay 15Buy14.95125,0001,868,75018,464,461May 15 05:25 PM
Avoro Capital Advisors LLCDirectorMay 14Buy15.40125,0001,925,00018,339,461May 15 05:25 PM
Avoro Capital Advisors LLCDirectorMay 13Buy15.07500,0007,535,00018,214,461May 15 05:25 PM